insulin premixed therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for insulin premixed therapy, covering 2014-10-16 to 2014-10-16. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up [Phase 3]